1 / 5

PharmaPoint: Atopic Dermatitis - India Drug Forecast

April 21st, 2015 – Navi Mumbai, India: Market Reports on India presents the report on "PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022" the coming decade could see the launch of the first biologic, which will set a precedent and pave the way for others to follow suit.

SophiaJones
Download Presentation

PharmaPoint: Atopic Dermatitis - India Drug Forecast

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 Market Reports On India www.marketreportsonindia.com

  2. Summary Although the past decade has seen the atopic dermatitis market remain relatively unchanged and a saturated, highly genericized arena, the coming decade could see the launch of the first biologic, which will set a precedent and pave the way for others to follow suit. Other events that are expected to invoke change to the previously stagnant atopic dermatitis market include the launch of a non-steroidal topical from Anacor, AN2728, generic erosion of branded topicals Protopic and Elidel in the US, and the increasing use of pharmacological treatments in the growing markets of India and China. Strong uptake of branded and generic topical calcineurin inhibitors as well as systemic vitamin derivatives will be the key growth drivers, while prescribing behavior of Indian dermatologists. Contact No: +91.22.27810772, 27810773 Email Id : info@marketreportsonindia.com

  3. Scope • Overview of Atopic Dermatitis including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape. • Detailed information on the key drugs in India including product description, safety and efficacy profiles as well as a SWOT analysis. • Sales forecast for the top drugs in India from 2012-2022. • Analysis of the impact of key events as well the drivers and restraints • affecting India Atopic Dermatitis market. Contact No: +91.22.27810772, 27810773 Email Id : info@marketreportsonindia.com

  4. Table of Contents Table of Contents Introduction Disease Overview Disease Management Competitive Assessment Opportunity and Unmet Need Pipeline Assessment Market Outlook Appendix Disclaimer Contact No: +91.22.27810772, 27810773 Email Id : info@marketreportsonindia.com

  5. To know more : PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 Contact Us : Ph : India : +91.22.27810772, 27810773Email : info@marketreportsonindia.comWeb : http://www.marketreportsonindia.com/

More Related